{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:12:33Z","timestamp":1746850353024,"version":"3.40.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Blood stream infection (BSI) represent a life-threatening condition. Thus, we aimed to investigate the role of procalcitonin (PCT) and C-reactive protein (CRP) tests in adult febrile patients with BSI and other clinical infections in hospitalized cancer cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Blood culture (BC) testing was performed using BACTEC 9120. Identification and antibiotic susceptibility were done by Vitek 2\u00ae. Multiplex PCR for the detection of carbapenemases genes produced by Enterobacteriaceae was carried out including <jats:italic>KPC<\/jats:italic>, <jats:italic>NDM<\/jats:italic>, <jats:italic>IMP<\/jats:italic>, <jats:italic>VIM<\/jats:italic>, and <jats:italic>Oxa-48<\/jats:italic> genes. Measurement of CRP was done via particle-enhanced immunoturbidimetric assay using Cobas C6000 autoanalyzer. PCT level was measured using the electrochemiluminescence immunoassay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Out of 101 febrile hospitalized adult cancer cases with clinical infection, 50 had positive BC, and 51 were positive for other infections (27 localized bacterial and 24 viral infections) with a negative BC. At a PCT cut-off value of 0.5\u00a0ng\/mL, PCT median values were significantly higher in BSI patients than those with other infections (<jats:italic>p<\/jats:italic>\u2009=\u20090.004), specifically with gram-negative BSIs (<jats:italic>p<\/jats:italic>\u2009=\u20090.007). Higher PCT values were significantly related to ICU admission and poor response to therapy, <jats:italic>p<\/jats:italic>\u2009=\u20090.004 and 0.002, respectively. The difference in CRP values between patients with BSI and other febrile cases was not statistically significant, <jats:italic>p<\/jats:italic>\u2009=\u20090.922.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Higher PCT values were significantly related to blood stream infections, gram-negative pathogens, ICU admission, and poor response to therapy. Procalcitonin could be used to assign severity of infection and monitor response to antimicrobial therapy in high-risk patients, thus reducing days of antibiotics days.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s43046-025-00283-1","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T23:02:06Z","timestamp":1746831726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High procalcitonin level is related to blood stream infections, gram-negative pathogens, and ICU admission in infections of adult febrile cancer patients"],"prefix":"10.1186","volume":"37","author":[{"given":"Hadir Ahmed","family":"El-Mahallawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nourhan Ahmed","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaf Mohamed El","family":"Banna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ghareeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"issue":"7","key":"283_CR1","doi-asserted-by":"publisher","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","volume":"14","author":"L Baden","year":"2016","unstructured":"Baden L, Swaminathan S, Angarone M, Blouin G, Camins B, Casper C. Prevention and treatment of cancer-related infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Comprehensive Cancer Netwk. 2016;14(7):882\u2013913. https:\/\/doi.org\/10.6004\/jnccn.2016.0093.","journal-title":"J Comprehensive Cancer Netwk"},{"issue":"1","key":"283_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12879-020-05181-6","volume":"20","author":"AM Jiang","year":"2020","unstructured":"Jiang AM, Shi X, Liu N, Gao H, Ren MD, Zheng XQ, Fu X, Liang X, Ruan ZP, Yao Y, Tian T. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology center in Western China. BMC Infect Dis. 2020;20(1):452\u201364. https:\/\/doi.org\/10.1186\/s12879-020-05181-6.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"283_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/14787210.2019.1562335","volume":"17","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Russo A, Righi E, Dolso E, Merelli M, D\u2019Aurizio F, Sartor A, Curcio F. Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology. Expert Rev Anti Infect Ther. 2019;17(2):99\u2013105. https:\/\/doi.org\/10.1080\/14787210.2019.1562335.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"283_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00277-019-03622-0","volume":"98","author":"M Kochanek","year":"2019","unstructured":"Kochanek M, Schalk E, Baildon M, Beutel G, Buchheidt D, Hentrich M, Henze L, Kiehl M, Liebregts T, Lilienfeld-Toal M, Classen A, Mellinghoff S, Penack O, Piepel C, Boll B. Management of sepsis in neutropenic cancer patients:2018 guidelines from the Infectious Diseases Working Party (AGIHO) Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2019;98:1051\u201369. https:\/\/doi.org\/10.1007\/s00277-019-03622-0.","journal-title":"Ann Hematol"},{"key":"283_CR5","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s001340000624","volume":"26","author":"K Reinhart","year":"2000","unstructured":"Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med. 2000;26:1193\u2013200. https:\/\/doi.org\/10.1007\/s001340000624.","journal-title":"Intensive Care Med."},{"issue":"1","key":"283_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt C, Wolff M, Chastre J, Tubach F. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95\u2013107. https:\/\/doi.org\/10.1016\/s1473-3099(17)30592-3.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"283_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/10408363.2021.1988047","volume":"59","author":"H Xu","year":"2022","unstructured":"Xu H, Tian M, Pan S-Y. Clinical utility of procalcitonin and its association with pathogenic microorganisms. Crit Rev Clin Lab Sci. 2022;59(2):93\u2013111. https:\/\/doi.org\/10.1080\/10408363.2021.1988047.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"283_CR8","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.21037\/jtd2019.11.63","volume":"12 Suppl 1","author":"C Gregoriano","year":"2020","unstructured":"Gregoriano C, Heilmann E, Molitor A, Schuetz P. Role of procacitonin use in the management of sepsis. J Thorac Dis. 2020;12 Suppl 1:S5-15. https:\/\/doi.org\/10.21037\/jtd2019.11.63.","journal-title":"J Thorac Dis."},{"issue":"7","key":"283_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/23744235.2018.1428824","volume":"50","author":"H El-Mahallawy","year":"2018","unstructured":"El-Mahallawy H, Zafer M, Amin M, Ragab M, Al-Agamy M. Spread of carbapenem resistant Enterobacteriaceae at tertiary care cancer hospital in Egypt. Infectious Dis. 2018;50(7):560\u20134. https:\/\/doi.org\/10.1080\/23744235.2018.1428824.","journal-title":"Infectious Dis"},{"key":"283_CR10","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.2147\/IJN.S173776","volume":"13","author":"P Li","year":"2018","unstructured":"Li P, Chen Z, Liu B, Li K, Wang H, Lin L, He L, Wei J, Liu T. Establishment of a novel homogeneous nanoparticle-based assay for sensitive procalcitonin detection of ultra-low-volume serum samples. Int J Nanomed. 2018;13:5395\u2013404. https:\/\/doi.org\/10.2147\/IJN.S173776.","journal-title":"Int J Nanomed"},{"issue":"1","key":"283_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00277-018-3494-3","volume":"98","author":"A Van de Louw","year":"2019","unstructured":"Van de Louw A, Lewis A, Yang Z. Autopsy findings in patients with acute myeloid leukemia and non-Hodgkin\u2019s lymphoma in the modern era: a focus on lung pathology and acute respiratory failure. Ann Hematol. 2019;98(1):119\u201329. https:\/\/doi.org\/10.1007\/s00277-018-3494-3.","journal-title":"Ann Hematol"},{"issue":"1","key":"283_CR12","doi-asserted-by":"publisher","first-page":"636-","DOI":"10.1186\/s12879-021-06243-z","volume":"21","author":"A Amanati","year":"2021","unstructured":"Amanati A, Sajedianfard S, Khajeh S, Ghasempour S, Mehrangiz S, Nematlahi S, Shahhosein Z. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance. BMC Infect Dis. 2021;21(1):636-. https:\/\/doi.org\/10.1186\/s12879-021-06243-z.","journal-title":"BMC Infect Dis."},{"issue":"7","key":"283_CR13","doi-asserted-by":"publisher","first-page":"e0130999","DOI":"10.1371\/journal.pone.0130999","volume":"10","author":"A-M Chaftari","year":"2015","unstructured":"Chaftari A-M, Hachem R, Reitzel R, Jordan M, Jiang Y, Yousif A, Garoge K, Deshmukh P, Al Hamal Z, Jabbour J, Hanania A, Raad S, Jamal M, Raad I. Role of procalcitonin and interleukin-6 in predicting cancer, and its progression independent of infection. PLoS One. 2015;10(7):e0130999. https:\/\/doi.org\/10.1371\/journal.pone.0130999.","journal-title":"PLoS One"},{"issue":"23","key":"283_CR14","doi-asserted-by":"publisher","first-page":"8475","DOI":"10.1002\/cam4.4355","volume":"10","author":"P Chaftari","year":"2021","unstructured":"Chaftari P, Chaftari AM, Hachem R, Yeung S, Dagher H, Jiang Y, Malek A, Dailey GN, Mulanovich V, Raad I. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: a useful alternative to the multinational association for supportive care in cancer score. Cancer Med. 2021;10(23):8475\u201382. https:\/\/doi.org\/10.1002\/cam4.4355.","journal-title":"Cancer Med"},{"key":"283_CR15","doi-asserted-by":"publisher","first-page":"627967","DOI":"10.3389\/fmed.2021.627967","volume":"8","author":"M Vassalo","year":"2021","unstructured":"Vassalo M, Michelangell C, Fabre R, Manni S, Genillier P, Weiss N, Blanchouin E, Saudes L, Kaphan R, Puchois A, Pradier C, Montagne N. Procalcitonin and C-reactive protein\/procalcitonin ratio as markers of infection in patients with solid tumors. Front Med. 2021;8:627967. https:\/\/doi.org\/10.3389\/fmed.2021.627967.","journal-title":"Front Med"},{"key":"283_CR16","doi-asserted-by":"publisher","first-page":"828569","DOI":"10.3389\/fped.2022.828569","volume":"10","author":"F Van der Velden","year":"2020","unstructured":"Van der Velden F, Gennery A, Emonts M. Biomarkers for diagnosing febrile illness in immunocompromised children: a systematic review of the literature. Front Pediatr. 2020;10:828569. https:\/\/doi.org\/10.3389\/fped.2022.828569.","journal-title":"Front Pediatr"},{"key":"283_CR17","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.2147\/IDR.S298920","volume":"14","author":"A El-Kholy","year":"2021","unstructured":"El-Kholy A, El-Mahallawy H, Elsharnouby N, Aziz M, Helmy A, Kotb R. Landscape of multidrug-resistant gram-negative infections in Egypt: survey and literature review. Infect Drug Resist. 2021;14:1905\u201320. https:\/\/doi.org\/10.2147\/IDR.S298920.","journal-title":"Infect Drug Resist"},{"issue":"12","key":"283_CR18","doi-asserted-by":"publisher","first-page":"e0225765","DOI":"10.1371\/journal.pone.0225765","volume":"14","author":"M Yang","year":"2019","unstructured":"Yang M, Choi S, Lee J, Lee D, Kim Y, Park Y, Oh E. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies. PLoS One. 2019;14(12):e0225765. https:\/\/doi.org\/10.1371\/journal.pone.0225765.","journal-title":"PLoS One"},{"issue":"5","key":"283_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/labmed\/lmab002","volume":"52","author":"K Arikan","year":"2021","unstructured":"Arikan K, Karadag-Oncel E, Aytac S, Cetin M, Cengiz A, Gumruk F, Kara A, Ceyhan M. 2021: Usage of plasma presepsin, C-reactive protein, procalcitonin and proadrenomedullin to predict bacteremia in febrile neutropenia of pediatric hematological malignancy patients. Lab Med. 2021;52(5):477\u201384. https:\/\/doi.org\/10.1093\/labmed\/lmab002.","journal-title":"Lab Med"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00283-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-025-00283-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00283-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T23:02:07Z","timestamp":1746831727000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-025-00283-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1186\/s43046-025-00283-1","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Faculty of Medicine, Cairo University (date May 2020). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}